Dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalization, and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes. That’s the main result of the DAPA-CKD trial presented in a Hot Line session today at ESC Congress 2020. The DAPA-CKD trial tested the hypothesis that […]
Home »
Decline in primary care visits continued after ACA
The long-term decrease in primary care contact was not interrupted following implementation of the Affordable Care Act (ACA), according to a study published in the November/December issue of the Annals of Family Medicine. Michael E. Johansen, M.D., from OhioHealth in Columbus, and Caroline R. Richardson, M.D., from University of Michigan in Ann Arbor, used data […]
Researchers report new findings on familial primary distal renal tubular acidosis
In addition to regulating the body’s fluid balance by excreting greater or smaller amounts of urine, the kidneys also maintain the proper balance of electrolytes (salts) and the pH (an acid-base equilibrium) of the body. Excess acid is secreted into the urine by healthy kidneys. This process takes place in a specific part of the […]
More High-Value Care Associated With Receipt of Primary Care
THURSDAY, Jan. 31, 2019 — Receipt of primary care is associated with significantly more high-value care, slightly more low-value care, and a better health care experience, according to a study published online Jan. 28 in JAMA Internal Medicine. David M. Levine, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues compared propensity score-weighted […]
Primary care doctors ‘not doing enough’ to curb STDs
Julie Lopez, 21, has been tested regularly for sexually transmitted diseases since she was a teenager. But when Lopez first asked her primary care doctor about screening, he reacted with surprise, she said. “He said people don’t usually ask. But I did,” said Lopez, a college student in Pasadena, Calif. “It’s really important.” Lopez usually […]
Engineered cancer cells can fight primary and metastatic cancer
What if cancer cells could be re-engineered to turn against their own kind? A new study led by researchers at Brigham and Women’s Hospital leverages the power of gene editing to take a critical step toward using cancer cells to kill cancer. The team reports promising results in preclinical models across multiple types of cancer […]